tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Technical Analysis

Compare
3,192 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is -8.47, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 94.34, while Sarepta Therapeutics’s (SRPT) share price is $74.1, making it a Sell.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 104.60, while Sarepta Therapeutics’s (SRPT) share price is $74.1, making it a Sell.

Sarepta Therapeutics (SRPT) Pivot Points

Mar 24, 2025, 05:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
63.72
68.39
70.92
75.59
78.12
82.79
85.32
Fibonacci
68.39
71.14
72.84
75.59
78.34
80.04
82.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Mar 24, 2025, 05:12 PM
Period
Simple
Exponential
MA5
80.48Sell
79.88Sell
MA10
89.81Sell
86.81Sell
MA20
97.38Sell
94.34Sell
MA50
107.69Sell
104.60Sell
MA100
115.01Sell
112.22Sell
MA200
124.92Sell
120.43Sell
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 86.81, while Sarepta Therapeutics’s (SRPT) share price is $74.1, making it a Sell.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 112.22, while Sarepta Therapeutics’s (SRPT) share price is $74.1, making it a Sell.
Sarepta Therapeutics’s (SRPT) stock price is $74.1 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 107.69, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $74.1 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 115.01, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $74.1 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 124.92, creating a Sell signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Mar 24, 2025, 05:12 PM
Name
Value
Implied Action
RSI (14)
27.90
Buy
STOCH (9,6)
8.83
Buy
STOCHRSI (14)
7.89
Buy
MACD (12,26)
-8.47
Buy
ADX (14)
35.76
Neutral
Williams %R
-96.98
Buy
CCI (14)
-181.78
Buy
ATR (14)
5.80
-
Ultimate Oscillator
28.83
Sell
ROC
-26.79
Sell
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 27.90, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 35.76, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is -181.78, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is -26.79, creating a Sell signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Sell.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 27.90, which suggests SRPT is a Buy.
      What is SRPT’s MACD?
      SRPT’s MACD is -8.47, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 80.48, which suggests SRPT is a Sell.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 97.38, which suggests SRPT is a Sell.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 107.69, which suggests SRPT is a Sell.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 124.92, which suggests SRPT is a Sell.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -96.98, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is -181.78, which suggests SRPT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis